Call us 24/7

hematologic oncology

Hematologic oncology

The Hematologic Oncology Department at Cancer Treatment Centers of America® (CTCA), Philadelphia, provides medical therapies for patients with blood-related diseases, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma.

Our hematologic oncology team has expertise in treating hematologic diseases using minimally invasive technologies and a personalized approach. We use diagnostic tests to develop an individualized treatment plan that’s tailored to your needs.

Helping you maintain your quality of life

Our hematologic oncology team will work with the rest of your care team to support your health needs throughout your treatment.

For example, your dietitian may recommend a healthy diet to help fortify your body, and your naturopathic clinician may suggest natural therapies to help reduce side effects, such as neuropathy. Your rehabilitation therapist may recommend safe levels of physical activity to help you stay active and independent.

Additionally, your pain management practitioner may use various techniques to help alleviate discomfort and control bone and neuropathic pain, while your mind-body therapist may provide counseling and relaxation techniques.

The hematologic oncology team at CTCA Philadelphia

When you first visit CTCA® Philadelphia, you’ll meet with the hematologic oncology team, which includes board-certified hematologic oncologists. Three key physicians on the team are Pamela Crilley, DO, David Topolsky, MD, and Ankur Parikh, DO.

Your doctor will review your medical records and determine whether you need additional diagnostic testing, such as lab work or imaging tests. Once you’ve completed necessary testing, your doctor will meet with you, answer your questions, and present you with options. Together, we'll develop a treatment plan that works for you.

Advanced medical therapies

Our Philadelphia hospital’s Hematologic Oncology Department provides advanced medical therapies for patients with various types and stages of hematologic disease, including:

  • Multiple myeloma
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • Leukemia (including ALL, AML, CLL, CML and myelodysplasia)

Stem cell transplantation

A stem cell transplant may be used to infuse healthy stem cells into the body to stimulate new bone marrow growth, suppress the disease and reduce the possibility of a relapse. Stem cells may be found in the bone marrow, circulating blood (peripheral blood stem cells) and umbilical cord blood.

For patients who need a stem cell transplant, our Stem Cell Unit includes an outpatient clinic, infusion center and inpatient rooms. When you first visit the hospital, you’ll meet with the hematologic oncology team. Your doctor will review your medical records and determine whether you need additional diagnostic testing, such as lab work or imaging tests.

Once you’ve completed testing, your doctor will present you with treatment options, which may include autologous or allogeneic stem cell transplants.

The hematologic oncology team will care for you throughout your treatment. You’ll stay in one of our private, inpatient rooms and receive around-the-clock monitoring and care. We’ll do everything possible to see that you and your family are comfortable throughout your stay.

Stem Cell Transplant and Cell Therapy Program FACT accreditation

In 2017, CTCA in Philadelphia was recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration.

FACT, an internationally recognized accrediting body for hospitals and medical institutions that offer stem cell transplantation, awarded our Philadelphia hospital the accreditation for meeting rigorous standards, including in the areas of clinical care, donor management, apheresis collection, processing, storage, transportation, autologous administration and cell release.

FACT accreditation is awarded after an evaluation of detailed clinical documentation and an on-site inspection to determine whether the organization complies with current FACT standards and the U.S. Food and Drug Administration’s rules for Good Tissue Practice. Since 2007, FACT accreditation has been used in determining the U.S. News & World Report rankings of transplant centers for the “America's Best Hospitals” list.